Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swift Institute is a private, commercial-stage multispecialty healthcare provider focused on musculoskeletal, spine, neurosurgery, neurology, vein, imaging, pain management, and rehabilitation services in Nevada. The organization was formed under a unified brand in 2022 after the merger and rebranding of Spine Nevada and Tahoe Fracture, in partnership with HOPCo. Swift Institute operates a broad outpatient specialty network that includes orthopedic and spine clinics, urgent care, physical therapy, imaging, and vein care. Rather than developing therapeutics, it delivers patient care services using advanced diagnostics, minimally invasive spine procedures, rehabilitation, and other specialty interventions. The company appears best characterized as a regional healthcare services organization rather than a biotech, pharma, or life sciences drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swift Institute.